Villeneuve-le-Roi, France

Jean C Aloup

This inventor holds 1 USPTO granted patent. Top assignee: Rhone-Poulenc Sante. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean C Aloup. Retrieved from https://idiyas.com/inventor/jean-c-aloup

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jean C Aloup

Introduction

Jean C Aloup is a notable inventor based in Villeneuve-le-Roi, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit gastric secretion. His work is essential for advancing treatments for gastric ulcers.

Latest Patents

Jean C Aloup holds a patent for "Thioformamide derivatives and use in inhibiting gastric secretion." This patent describes thioformamide derivatives that can be synthesized through specific chemical reactions involving amines and thioesters. The compounds are designed to be effective inhibitors of gastric secretion, making them valuable in the treatment of gastric ulcers.

Career Highlights

Throughout his career, Jean C Aloup has been associated with Rhone-Poulenc Santé, a company known for its focus on health and pharmaceutical innovations. His work has contributed to the development of new therapeutic options for patients suffering from gastric conditions.

Collaborations

Jean C Aloup has collaborated with notable colleagues such as Jean Bouchaudon and Daniel Farge. These partnerships have likely enhanced the research and development processes within their projects.

Conclusion

Jean C Aloup's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to impact the treatment of gastric ulcers positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…